| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely efmoroctocog alfa 2000 international unit/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely efmoroctocog alfa 250 international unit/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Efmoroctocog alfa 3000 international unit powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely efmoroctocog alfa 500 international unit/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Olanzapine 10 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely parecoxib (as parecoxib sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Thyrotropin alfa 900 microgram powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Powder for conventional release solution for infusion or injection (dose form) |
est un(e) (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| lyophilisat et solvant pour solution injectable |
est un(e) (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely degarelix 80 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely degarelix 120 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cefazolin (as cefazolin sodium) 10 g powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefazolin (as cefazolin sodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cefmetazole sodium 2g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Penicillin g benzathine 150000iu/penicillin g procaine 150000iu powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Penicillin g benzathine 900000iu/penicillin g procaine 300000iu powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| poudre de 250 mg d'immunoglobuline contre le virus varicella-zoster pour solution injectable en flacon (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Hepatitis B immunoglobulin 200iu powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely bleomycin (as bleomycin sulfate) 30 unit/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Hepatitis B immunoglobulin 500iu powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Anidulafungin 50 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cefmetazole sodium 1g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ampicilline 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Trastuzumab 440 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely telavancin (as telavancin hydrochloride) 750 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefotetan (as cefotetan disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Hyaluronidase 1500 unit powder for solution for injection ampule |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Warfarin 2mg/mL powder for injection solution (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely pemetrexed (as pemetrexed disodium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Metronidazole hydrochloride 500mg powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Digoxin specific antibody 38mg powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Human alpha1 proteinase inhibitor 1000mg powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cephapirin sodium 1g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Agalsidase beta 5 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely sodium nitroprusside dihydrate 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cefazolin 250mg powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| poudre de 125 UI d'immunoglobuline contre le virus varicella-zoster pour solution injectable en flacon |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cefotetan disodium 10g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftazidime 3 g, flacon de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| aztréonam 1 g, fiole de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ticarcillin 3g/clavulanic acid 100mg powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| L-asparaginase 10,000iu powder for injection solution 10mL vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| aztréonam 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| amoxicilline et clavulanate de potassium 500 mg/100 mg, fiole de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Metaiodobenzylguanidine[131I] 37MBq/mL powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Sodium iodide[131I] 37-7400MBq powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely ampicillin (as ampicillin sodium) 2 gram and sulbactam (as sulbactam sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Factor VIII 500iu/von Willebrand factor 1250iu powder for injection solution (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely azathioprine 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| 6-Iodomethylnorcholesterol[131I] 8-30MBq/mL powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| amoxicilline et clavulanate de potassium 1 mg/200 mg, fiole de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Nafcillin (as nafcillin sodium) 2 g powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Doripenem (as doripenem monohydrate) 500 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Chromic phosphate[32P] 185MBq/mL powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Metaiodobenzylguanidine[123I] 74MBq/mL powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Gentamicin 1g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefepime (as cefepime hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Human chorionic gonadotropin 10,000iu powder and solvent for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Polymyxin B sulfate 500,000u powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Factor VIII 1000iu/von Willebrand factor 2500iu powder for injection solution (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Bacitracin 5000000units powder for injection solution bottle (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| ceftazidime 250 mg, flacon de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| aztréonam 2 g, fiole de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Rhenium[186Re]etidronate 1.3GBq/mL powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ticarcillin disodium 1g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| pantoprazole 40 mg, fiole de poudre pour injection (médicament clinique) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Rilonacept 220mg powder for injection solution 20ml vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| céfazoline 500 mg, fiole de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Cefoxitin sodium 10g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| céfazoline 1 g, fiole de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely bleomycin (as bleomycin sulfate) 15 unit/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Urokinase 250000iu powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Urea 40g powder for injection solution 200mL bottle (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| céfoxitine 1 g, fiole de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ticarcillin disodium 20g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Folinic acid 15mg powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Folinic acid 30mg powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Amobarbital sodium 500 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| capréomycine 1 g, fiole de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Ticarcillin disodium 3g powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Azithromycin (as azithromycin dihydrate) 500 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Palifermin 6.25 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Chlorothiazide 500 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| méropenem 1 g, fiole de poudre pour solution injectable (médicament clinique) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Abatacept 250mg powder for injection solution 15mL vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Factor IX concentrate 1000iu powder for injection solution 20mL vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial |
a une forme pharmaceutique (attribut) |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
| Thyrotropin alfa 0.9mg/mL powder for injection solution vial (product) |
a une forme pharmaceutique (attribut) |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
FHIR